ES2065846B1 - PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE. - Google Patents

PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE.

Info

Publication number
ES2065846B1
ES2065846B1 ES9300826A ES9300826A ES2065846B1 ES 2065846 B1 ES2065846 B1 ES 2065846B1 ES 9300826 A ES9300826 A ES 9300826A ES 9300826 A ES9300826 A ES 9300826A ES 2065846 B1 ES2065846 B1 ES 2065846B1
Authority
ES
Spain
Prior art keywords
agents
steroid
present
pharmaceutical formulation
inflammatory agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9300826A
Other languages
Spanish (es)
Other versions
ES2065846A1 (en
Inventor
Wie Bergamini Michael Van
Mas Jose Alberto Vallet
Laguens Carmen Oros
Cabrera Antonio Lopez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Cusi SA
Original Assignee
Laboratorios Cusi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Cusi SA filed Critical Laboratorios Cusi SA
Priority to ES9300826A priority Critical patent/ES2065846B1/en
Publication of ES2065846A1 publication Critical patent/ES2065846A1/en
Application granted granted Critical
Publication of ES2065846B1 publication Critical patent/ES2065846B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FORMULACION FARMACEUTICA A BASE DE UN AGENTE ANTIINFLAMATORIO ESTEROIDICO O NO ESTEROIDICO Y UN ANTIBIOTICO PERTENECIENTE AL GRUPO DE LOS INHIBIDORES DE LA ADN GIRASA PARA SU UTILIZACION TOPICA OFTALMICA COMPRENDE: 0,001-5,0% DE UN AGENTE ANTIINFLAMATORIO ESTEROIDICO O NO ESTEROIDICO O UN ISOMERO, O UN ESTER, O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES; 0,05-5,0% DE UN INHIBIDOR DE LA ADN GIRASA, O UN ISOMERO, O UN ESTER O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES; Y OPCIONALMENTE, UNO O MAS INGREDIENTES SELECCIONADOS ENTRE AGENTES ISOTONIZANTES, AMORTIGUADORES DEL PH, AGENTES VISCOSIZANTES, AGENTES HUMECTANTES, AGENTES QUELANTES, AGENTES ANTIOXIDANTES Y/O AGENTES CONSERVADORES, ADEMAS DE UNO O VARIOS EXCIPIENTES ADECUADOS A LA FORMA DE PRESENTACION FARMACEUTICA DE LA FORMULACION. DICHA FORMULACION PRESENTA UN PH COMPRENDIDO ENTRE 4 Y 9. APLICACION EN EL TRATAMIENTO DE PROCESOS INFLAMATORIOS OCULARES ACOMPAÑADOS DE INFECCION.PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GROUP OF GYRASE DNA INHIBITORS, INCLUDES: A NON-STERILE NON-STERILE ANTI-PHYSICAL AGENT OR AN ESTER, OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS; 0.05-5.0% OF A GYRASE DNA INHIBITOR, OR AN ISOMER, OR AN ESTER OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS; AND OPTIONALLY, ONE OR MORE SELECTED INGREDIENTS AMONG ISOTONIZING AGENTS, SHOCK ABSORBERS, VISCOSIZING AGENTS, WETTING AGENTS, CHEATING AGENTS, ANTIOXIDANT AGENTS AND / OR PRESENT AGENTS, SEARCHERS OF EXPANDING LAWYERS, ADEMENTS, PRESENT TOWARDS, EXPANDING DEMANDERS, PRESENT AGENTS, AND SEEKERS WHO ARE PRESENT TOWARD DEMONSTRAINERS, PRESENT AGENTS, AND SEEKERS WHO ARE PRESENT TOWARD ANYOXIDANTS AND PRESENT AGENTS. THE FORMULATION PRESENTS A PH INCLUDED BETWEEN 4 AND 9. APPLICATION IN THE TREATMENT OF EYE INFLAMMATORY PROCESSES ACCOMPANIED BY INFECTION.

ES9300826A 1993-04-20 1993-04-20 PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE. Expired - Fee Related ES2065846B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9300826A ES2065846B1 (en) 1993-04-20 1993-04-20 PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9300826A ES2065846B1 (en) 1993-04-20 1993-04-20 PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE.

Publications (2)

Publication Number Publication Date
ES2065846A1 ES2065846A1 (en) 1995-02-16
ES2065846B1 true ES2065846B1 (en) 1995-10-01

Family

ID=8281527

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9300826A Expired - Fee Related ES2065846B1 (en) 1993-04-20 1993-04-20 PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE.

Country Status (1)

Country Link
ES (1) ES2065846B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2105971B1 (en) * 1995-08-02 1998-07-01 S A L V A T Lab Sa ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
DE19729879C2 (en) * 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Storage stable ophthalmic compositions comprising diclofenac and ofloxacin
US6552020B1 (en) 1999-07-30 2003-04-22 Allergan, Inc. Compositions including antibiotics and methods for using same
CN1158994C (en) * 1999-09-24 2004-07-28 爱尔康公司 Topcial suspension formulations containing ciprofloxacin and dexa methasone
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US20030139382A1 (en) 2001-09-21 2003-07-24 Alcon, Inc. Method of treating middle ear infections
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US7514451B2 (en) 2003-09-10 2009-04-07 Kyorin Pharmaceutical Co., Ltd. 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
CN102647971B (en) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 For comprising the container of the compositions of meloxicam
BR112012022073A2 (en) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh use of meloxicam for the long-term treatment of musculoskeletal disorders in cats.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EP2502616A1 (en) * 2011-03-21 2012-09-26 Matthew Krayenbuhl Pharmaceutical nasal composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3704907A1 (en) * 1987-02-17 1988-08-25 Bayer Ag TOPICALLY APPLICABLE PREPARATIONS OF GYRASE INHIBITORS IN COMBINATION WITH CORTICOSTEROIDS
AU4201189A (en) * 1988-08-26 1990-03-23 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
IL98179A0 (en) * 1990-05-21 1992-06-21 Norwich Eaton Pharma Pharmaceutical compositions containing phenylpropanolamine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position

Also Published As

Publication number Publication date
ES2065846A1 (en) 1995-02-16

Similar Documents

Publication Publication Date Title
ES2065846B1 (en) PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE.
ECSP941104A (en) DERIVATIVES OF 2,6 DIAMINOPURINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
AR050838A1 (en) PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF OPTICAL INFECTION
ES2186015T3 (en) DERIVATIVES OF 2- (PURIN-9-IL) -TETRAHIDROFURAN-3,4-DIOL.
AR044923A1 (en) IMIDAZOQUINOLINAS REPLACED WITH SULFONAMIDE
PA8499101A1 (en) COMPOSITION OF CLINDAMYCIN INTRAVAGINAL OVULES
ES2068862T3 (en) DERIVATIVE OF 3'-HYDROXIBENZOXAZINORIFAMICINA; PROCEDURE FOR THE PREPARATION OF THE SAME AND ANTIBACTERIAL AGENT THAT CONTAINS THE SAME.
ES2079589T3 (en) PHARMACEUTICAL AGENTS.
PA8451801A1 (en) DERIVATIVES OF 9-OXYME ERYTHROMYCIN
PA8485601A1 (en) AZALIDAS OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS.
MX9400037A (en) OPHTHALMIC COMPOSITION FOR THE TREATMENT OF GLAUCOMA AND EYE HYPERTENSION.
CO5261519A1 (en) NEW BENZOIMIDAZOL DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS
AR024998A1 (en) NEW RETINOIDS FOR THE TREATMENT OF THE DISEASE
ES2183817T3 (en) METAZOAR PARASATIS PROTEASES INIBIDORS.
AR007021A1 (en) DERIVATIVES OF 3-DESCLADINOSA-2,3-ANHIDROERITROMICINA, PROCEDURES FOR ITS PREPARATION, COMPOUNDS FOR ITS EXCLUSIVE USE IN SUCH PROCEDURES AND PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION TO TREAT BACTERIAL INFECTIONS AND THE USE OF THESE COMPUTERS
MX9300399A (en) HETEROTRICICLIC DERIVATIVES.
MX9205123A (en) DERIVATIVES OF 5-HYDROXY-2-PIRIMIDINYL METHYLENE USEFUL AS ANTI-INFLAMMATORY AGENTS.
ES2078175B1 (en) PHARMACEUTICAL FORMULATION CONTAINING CLOBETASONE AND TOBRAMYCIN AND ITS APPLICATIONS.
ECSP055625A (en) BETA-LACTAMASA INHIBITOR PROFARMACO
AR006345A1 (en) A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INCLUDING AN HIV PROTEASE INHIBITOR AND A WATER-SOLUBLE TOCOFEROL DERIVATIVE, AND A METHOD FOR PREPARING SUCH COMPOSITION.
AR025351A1 (en) PAR SELECTIVE RETINOID AGONISTS
ES2171743T3 (en) DERIVATIVES OF AMIDINES AND ISOTIOURES AS INHIBITORS OF THE SYNTHETIC ENZYME OF NITRIC OXIDE.
ES2123821T3 (en) SPRAY FORMULATION THAT HAS A REFRESHING EFFECT.
CO5261624A1 (en) NEW FENILHETEROALQUILAMINE DERIVATIVES, PROCESSES FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH NEW NOVEDOUS DERIVATIVES AND THEIR USE IN THERAPY
AR041999A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AMBROXOL AND ISOPROPAMIDE IODURE

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20101018